A potential immunotherapy target for breast cancer: parenchymal and immune-stromal expression of the NLRP3 inflammasome pathway. Zhu QM, Li HX, Ma PQ, Wu LX, et al. BMC Cancer 2023;23:1163.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhu QM, Li HX, Ma PQ, Wu LX, et al. A potential immunotherapy target for breast cancer: parenchymal and immune-stromal expression of the NLRP3 inflammasome pathway. BMC Cancer 2023;23:1163.
PMID: 38031068